Solubility Enhancement Strategies Used by Modern CDMOs
Solubility enhancement has become a critical driver of modern drug development. For poorly soluble APIs, BCS Class II and IV compounds, and complex formulations, improving solubility ensures consistent absorption, reliable pharmacokinetics, and predictable clinical outcomes where standard formulation approaches often fail. The strategic value is clear. Enhanced solubility enables lower doses, reduces variability across diverse […]